BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 770496)

  • 1. The functional changes of the pituitary gonadotrophs during the menstrual cycle.
    Wang CF; Lasley BL; Lein A; Yen SS
    J Clin Endocrinol Metab; 1976 Apr; 42(4):718-28. PubMed ID: 770496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The two pools of pituitary gonadotropin: regulation during the menstrual cycle.
    Hoff JD; Lasley BL; Wang CF; Yen SS
    J Clin Endocrinol Metab; 1977 Feb; 44(2):302-12. PubMed ID: 320220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
    Lasley BL; Wang CF; Yen SS
    J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle.
    Grimes EM; Thompson IE; Taymor ML
    Acta Endocrinol (Copenh); 1975 Aug; 79(4):625-34. PubMed ID: 1098349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypersensitivity of the human gonadotrophs to the repeated administration of small doses of LH-RH.
    Faure N; Olivier GC
    Horm Res; 1978; 9(1):12-21. PubMed ID: 338460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The two pools of pituitary gonadotropin: regulation during the menstrual cycle.
    Hoff JD; Lasley BL; Wang CF; Yen SS
    J Clin Endocrinol; 1977 Feb; 44(2):302-12. PubMed ID: 12334943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a superactive luteinizing hormone-releasing factor agonist on gonadotropin and ovarian function during the menstrual cycle.
    Sheehan KL; Casper RF; Yen SS
    Am J Obstet Gynecol; 1979 Nov; 135(6):759-63. PubMed ID: 386801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle.
    Jewelewicz R; Dyrenfurth I; Ferin M; Bogumil J; Vande Wiele RL
    J Clin Endocrinol Metab; 1977 Oct; 45(4):662-7. PubMed ID: 334788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
    J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin secretion in response to low and high doses of LRF in normal and hypogonadal women (functional disparity of the gonadotrophs).
    Wang CF; Lasley BL; Yen SS
    J Clin Endocrinol Metab; 1976 Mar; 42(3):427-31. PubMed ID: 767351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine consequences of continuous antiestrogen therapy with tamoxifen in premenopausal women.
    Sherman BM; Chapler FK; Crickard K; Wycoff D
    J Clin Invest; 1979 Aug; 64(2):398-404. PubMed ID: 110834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LHRH and steroid levels in normal ovulatory women.
    Stone SC; Dickey RP; Kastin AJ; Schally AV
    Obstet Gynecol; 1976 Aug; 48(2):146-9. PubMed ID: 781572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human inhibin-A administered early in the menstrual cycle alters concurrent pituitary and follicular, plus subsequent luteal, function in rhesus monkeys.
    Molskness TA; Woodruff TK; Hess DL; Dahl KD; Stouffer RL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4002-6. PubMed ID: 8923851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in pituitary desensitization and prolongation of gonadotropin release by estrogen during continuous administration of gonadotropin-releasing hormone in women: its antagonism by progesterone.
    Araki S; Chikazawa K; Motoyama M; Ijima K; Abe N; Tamada T
    J Clin Endocrinol Metab; 1985 Mar; 60(3):590-8. PubMed ID: 3919050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of progesterone and the antiprogestin RU 486 on gonadotropin secretion in the follicular phase of the menstrual cycle.
    Permezel JM; Lenton EA; Roberts I; Cooke ID
    J Clin Endocrinol Metab; 1989 May; 68(5):960-5. PubMed ID: 2497130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct evidence of estrogen modulation of pituitary sensitivity to luteinizing hormone-releasing factor during the menstrual cycle.
    Wang CF; Yen SS
    J Clin Invest; 1975 Jan; 55(1):201-4. PubMed ID: 1088908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin enhances the luteinizing hormone and follicle-stimulating hormone responses to gonadotropin-releasing hormone in the follicular, but not in the luteal, menstrual phase.
    Cagnacci A; Paoletti AM; Soldani R; OrrĂ¹ M; Maschio E; Melis GB
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1095-9. PubMed ID: 7714075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessments of the functional capacity of the gonadotrophs in men: effects of estrogen and clomiphene.
    Lasley BL; Wang CF; Yen SS
    J Clin Endocrinol Metab; 1976 Jul; 43(1):182-9. PubMed ID: 780364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulsatile gonadotropin secretion during the human menstrual cycle: evidence for altered frequency of gonadotropin-releasing hormone secretion.
    Reame N; Sauder SE; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1984 Aug; 59(2):328-37. PubMed ID: 6429184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human recombinant activin-A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis, during the menstrual cycle in rhesus monkeys.
    Stouffer RL; Woodruff TK; Dahl KD; Hess DL; Mather JP; Molskness TA
    J Clin Endocrinol Metab; 1993 Jul; 77(1):241-8. PubMed ID: 8325947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.